Ranitidine - Generic Drug Details

Summary for ranitidine

US Patents:	0
Tradenames:	9
Applicants:	48
NDAs:	85
Drug Master File Entries:	43
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	51
Clinical Trials:	111
Patent Applications:	5
Drug Prices:	Drug price trends for ranitidine
What excipients (inactive ingredients) are in ranitidine?	ranitidine excipients list
DailyMed Link:	ranitidine at DailyMed

See drug prices for ranitidine

See drug sales revenues for ranitidine

Recent Clinical Trials for ranitidine

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Cairo University	NA
Beijing Wehand-Bio Pharmaceutical Co., Ltd	PHASE1
Cancer Institute and Hospital, Chinese Academy of Medical Sciences	PHASE1

See all ranitidine clinical trials

Generic filers with tentative approvals for RANITIDINE

Applicant	Application No.	Strength	Dosage Form
		15MG/ML	Solution; Oral

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for ranitidine

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Thinq Pharm-cro Pvt	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	210250-001	Aug 30, 2019		DISCN	No	No
Perrigo R And D	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	091429-002	May 11, 2011		DISCN	No	No
Dr Reddys Labs Ltd	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	075294-001	Mar 28, 2000		OTC	No	No
Dr Reddys Labs Ltd	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	078192-001	Aug 31, 2007		OTC	No	No
Dr Reddys Labs Inc	RANITIDINE HYDROCHLORIDE	ranitidine hydrochloride	TABLET;ORAL	076705-002	Jul 27, 2005	AB	RX	No	No